Royal Bank of Canada »

Avalo Therapeutics Ord shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0k 138 7.25

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Avalo Therapeutics Ord

FNY Investment Advisers
Banque Cantonale Vaudoise
Royal Bank of Canada
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
UBS Group
Advisor Group Holdings

View all funds holding Avalo Therapeutics Ord